News and Trends 3 May 2017
External Contributor
About
Many authors are contributing to Labiotech.eu. If you want to join them, feel free to reach out to us with your article ideas.
Articles by External Contributor
News and Trends 2 May 2017
Entrepreneurs, Academics & Entrepreneurial Academics succeed in Berlin
With Berlin’s plethora of life science research and academia, opportunities abound for biotech entrepreneurs. Here’s how the city bridges the gap between science and business! So much research, so many opportunities for academics and entrepreneurs. Berlin boasts 35 large research institutions focused on life sciences, and around 130 hospitals — including Europe’s largest and most […]
In Depth 27 Apr 2017
Spain: An Emerging Star in the European Biotech Community
Take note, Spain is becoming a new hotspot for biotech in Europe. More than €400M of venture capital, counting recent fundraising and anticipated closings, is forecasted to be available this year to fund the creation and growth of start-ups in the life sciences sector. Behind the growing interest among investors are novel opportunities with breakthrough potential […]
News and Trends 18 Apr 2017
Patent Eligibility: How to Tell if your Life Science Invention is Patentable
So you have an invention, but can you protect it with a patent? This primer will teach you about the criteria, from non-obviousness to inventiveness. How do we define “patent eligibility“? Broadly, the term means that an invention falls within a category of inventions for which the patent laws provide patent protection in general. Inventions […]
News and Trends 13 Apr 2017
Coming from Behind: How Italy is Revamping its Biotech Industry
Italy’s biotech industry lags behind in Europe, but the situation is starting to change with coordinated efforts in research, finance and organization. While ‘European biotech’ brings to mind France, Germany and the UK, Italy is cultivating its own thriving ecosystem. It claims internationally renowned scientific research institutions, including the University of Perugia and the San Raffaele […]
News and Trends 12 Apr 2017
Taking Cell Therapy one Step Further with this Boost Reagent
Cell therapy is revolutionizing medicine, here’s how the latest technology can help overcome the major challenges stopping it from taking over the market. Offering unprecedented possibilities to treat some of the most challenging diseases, cell therapy is stealing the show in the biotech space. Strimvelis, the first hematopoietic stem cell (HSC) gene therapy is already […]
ADVERTISEMENT
ADVERTISEMENT
In Depth 11 Apr 2017
Social Impact and Biotech: A Founder Revisits the Business Models
A recent article published on Labiotech.eu provided some high-level insight into whether or not non-profit structures are suitable for biotechnology companies. In this article we dig a little deeper, and challenge some of the assumptions and hypotheses presented. Across the globe, there is a new movement of entrepreneurs emerging, which value making a positive impact with their […]
News and Trends 6 Apr 2017
How is Biotech Transforming Pharma’s R&D Model?
Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances and acquisitions play in this new model? For almost two centuries, medicinal products have brought continuous therapeutic progress. This path is marked by breakthrough innovations, which now allow us to treat diseases previously believed to be incurable. But to bring about […]
Infographics 5 Apr 2017
Infographic: Europe’s Best Biotechs Mining the Microbiome
We gathered the best of the best companies in Europe working on therapies from the microbiome — here are the names you should know! Justine Braguy is pursuing a PhD at the Heinrich Heine Universität in Düsseldorf and KAUST in Saudi Arabia after obtaining a Masters in Biotechnology at Ecole Supérieure de Biotechnologie de Strasbourg (ESBS). In her spare […]
News and Trends 5 Apr 2017
Planning a Clinical Trial – Think Smart Design
By using smart designs, sponsors can save time and money while optimizing the knowledge accrued during the development of their products. “Traditional” study designs and statistical methodology do not allow changing the main features of a study protocol once the study has been initiated. The use of interim analyses, and in particularly the development of […]
News and Trends 4 Apr 2017
Sample a More Efficient Sorbent to Streamline your mAb Purification
Need an efficient way to purify your antibodies but struggle to find the best column? Pall Life Sciences is giving you the opportunity to try their solution for free. Enter your email below and receive your KANEKA Protein A sorbent sample! Pall Life Sciences is giving you a chance to try for free the new, […]
Interview 3 Apr 2017
Meet the Co-Founder who says DNA is the Next Silicon
DNA Script opens the door to a whole new age of manufacturing synthetic DNA. Thomas Ybert, was only 30 when he co-founded the company – here’s his story! Based in Paris, DNA Script produces synthetic DNA using a proprietary template-free enzymatic technology. Most of the manufactured DNA is currently synthesized by chemical means, but this startup […]
ADVERTISEMENT
